Lofexidine-structure (Lofexidien Structure)
Lofexidine Tablet, Coated
Product Images NDC 71921-250
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lofexidine (NDC 71921-250). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Florida Pharmaceutical Products, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Lofexidine-carton-96-tablets (Lofexidine Carton 96 Tablets)
This text appears to be related to the medication Lofexidine tablets. The description includes information on storage requirements, dosage details, manufacturer information, and contact details for Florida Pharmaceutical Products, LLC. It is important to store the tablets in their original container, protect them from heat and moisture, and keep them out of reach of children. For full prescribing information, the package insert should be referred to.*
Lofexidine-container-96-tablets (Lofexidine Container 96 Tablets)
Each tablet contains Lofexidine 0.18 mg, equivalent to 0.2 mg of lofexidine hydrochloride. It is advised to store between 15°C to 30°C (59°F to 86°F), away from heat and moisture. These Lofexidine Tablets are manufactured by Indoco Remedies Limited in India, for Florida Pharmaceutical Products, LLC in Boca Raton, FL. The package insert should be consulted for full prescribing information. Keep out of reach of children, store in the original container, protect from heat and moisture, and keep the bottle tightly closed. Contact toll-free number 1-800-315-0985 for FPP, 96 Tablets.*
Fig-1 (Lofexidine Fig 1)
Not available.*
Fig-2 (Lofexidine Fig 2)
This text refers to the mean score from the Subjective Opiate Withdrawal Scale-Gossop. The SOWS-Gossop is a tool used to assess the severity of opiate withdrawal symptoms. The mean score indicates the average level of withdrawal symptoms experienced by a group or individual.*
Fig-3 (Lofexidine Fig 3)
Lofexidine is a medication utilized to alleviate symptoms of opioid withdrawal. The dose provided in this text is 2.88 mg, compared to a placebo. This medication is typically prescribed to manage symptoms such as anxiety, muscle aches, sweating, and agitation during the withdrawal process.*
Fig-4 (Lofexidine Fig 4)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
